<DOC>
	<DOCNO>NCT01882166</DOCNO>
	<brief_summary>The number child conceive assisted reproductive technology increase Nordic country well worldwide . An important factor success treatment infertility short `` time pregnancy '' impact economical aspect society medical psychological aspect couple . During treatment , success relies 1 ) optimal stimulation growth maturation multiple follicle administration exogenous follicle stimulate hormone ( FSH ) , 2 ) selection fertilize egg / embryo high potential implantation transfer mother . In present project stimulation egg production human urine derive FSH ( Fostimon® ) recombinant FSH ( Puregon® ) compare . To end early embryo development kinetics fertilization evaluate . The system use time-lapse record embryo morphology first day embryo development mean embryoscope . Aim study investigate Puregon urinary Fostimon different effect embryo quality . The hypothesis study stimulation egg production two type follicle stimulate hormone effect early embryo quality .</brief_summary>
	<brief_title>Time-lapse Monitoring Early Embryo Development After Ovarian Stimulation During Infertility Treatment</brief_title>
	<detailed_description />
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Infertility , Female</mesh_term>
	<criteria>First second intracytoplasmic sperm injection ( ICSI ) treatment BMI 1832 kg/m² No previous ovarian hyperstimulation syndrome ( OHSS ) Regular menstrual cycle ( cycle length 28 ± 3 day Less 20 antral follicle evaluate vaginal ultrasound S AntiMüller Hormone ( AMH ) 10 40 pmol/L give informed consent</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>38 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Fertilization Vitro</keyword>
	<keyword>Sperm Injections , Intracytoplasmic</keyword>
	<keyword>Follicle Stimulating Hormone</keyword>
	<keyword>Embryonic Development</keyword>
</DOC>